TickerSutra

NSE: VINATIORGA · BSE: 524200 · ISIN INE410B01037

Vinati Organics Limited stock analysis

Vinati Organics Limited ranks #474 in the TickerSutra evidence-ranked universe with a score of 64/100 and 95% data confidence. The latest captured fundamentals show ROCE of 21.4%, quarterly sales growth of 28.7% and quarterly profit growth of 9.6%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE64/100

Monitor only

#474 of 5,430 ranked equities
Market capitalisation₹13,920.26cr
ROCE21.4%
Quarterly sales growth28.7%
Quarterly profit growth9.6%
P/E ratio27.9×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • ROCE is 21.4%
  • Low debt/equity of 0×
  • Strong CFO/EBITDA of 0.91×
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • No calculated threshold risk in the current snapshot.

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹1,616cr₹435cr₹347cr27.0%
2023₹2,066cr₹573cr₹419cr28.0%
2024₹1,900cr₹471cr₹323cr25.0%
2025₹2,248cr₹587cr₹415cr26.0%
2026₹2,228cr₹689cr₹488cr31.0%
TTM₹2,384cr₹704cr₹499cr30.0%
Debt / equity0.00×
CFO / EBITDA0.91×
Operating margin30.0%
Free cash flow₹491cr
Sales CAGR · 3Y2.5%
Profit CAGR · 3Y5.2%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts9 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Capacity expansion plansHigh severity · 4 mentions
Positive catalyst

In FY 2026, we incurred approximately INR270 crores in capex, including investments in V OPL towards capacity expansion, new product development and operational scalability. We successfully completed our ATBS capacity expansion during the year, significantly enhancing our ability to meet growing demand. Our commitment to innovation remains strong.

Demand slowdownCritical severity · 2 mentions
Negative warning

IB and HP -MTBE reported a stable performance during the year, and we expect both products to achieve double - digit growth in FY 2027. IBB volume declined by approximately 20% compared to FY 2025. This is partly attributed to the unavailability of key raw materials involved in the manufacturing of IBB on account of Iran war.

Pricing pressureModerate severity · 3 mentions
Negative warning

And my second question is more on the industry level. So the sector has faced many headwinds such as channel destocking, pricing pressure, Chinese overcapac ity, U.S. So where is the industry headed now?

Backward integrationLow severity · 1 mention
Watch

Archit Joshi: I have 2 quick questions. In VOPL, the line of products that we are planning earlier within which I believe 4 -MAP is facing certain challenges due to backward integration done by a few customers. Have we made any plans to discontinue t hat?

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…